Guido Hildebrandt

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Prognostic Factors

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Markus Diefenhardt, Anke Schlenska-Lange, Thomas Kuhnt, Simon Kirste, Pompiliu Piso, Wolf O Bechstein, Guido Hildebrandt, Michael Ghadimi, Ralf-Dieter Hofheinz, Claus Rödel, Emmanouil Fokas, null null
Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints Revisited. Cancers 14 (15) (2022)